Vontobel Holding
WST icon

Vontobel Holding’s West Pharmaceutical WST Stock Holding History

Vontobel Holding’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$809K Sell
2,254
-20
-0.9% -$6.12K ﹤0.01% 885
2026
Q1 		$570K Buy
2,274
+314
+16% +$78.1K ﹤0.01% 800
2025
Q4 		$539K Sell
1,960
-121
-6% -$33.1K ﹤0.01% 962
2025
Q3 		$546K Sell
2,081
-599
-22% -$146K ﹤0.01% 918
2025
Q2 		$586K Buy
2,680
+17
+0.6% +$3.63K ﹤0.01% 850
2025
Q1 		$596K Sell
2,663
-206
-7% -$56.8K ﹤0.01% 728
2024
Q4 		$940K Buy
2,869
+175
+6% +$55.1K ﹤0.01% 615
2024
Q3 		$809K Buy
2,694
+316
+13% +$96.8K ﹤0.01% 646
2024
Q2 		$783K Sell
2,378
-224
-9% -$79.2K ﹤0.01% 636
2024
Q1 		$1.03M Buy
2,602
+127
+5% +$47K 0.01% 578
2023
Q4 		$871K Sell
2,475
-148
-6% -$52.4K 0.01% 632
2023
Q3 		$984K Sell
2,623
-350
-12% -$135K 0.01% 587
2023
Q2 		$1.14M Sell
2,973
-1,474
-33% -$527K 0.01% 565
2023
Q1 		$1.54M Sell
4,447
-1,658
-27% -$484K 0.01% 479
2022
Q4 		$1.41M Buy
6,105
+698
+13% +$165K 0.01% 493
2022
Q3 		$1.33M Sell
5,407
-13
-0.2% -$3.96K 0.02% 484
2022
Q2 		$1.62M Sell
5,420
-1,155
-18% -$376K 0.02% 426
2022
Q1 		$2.75M Sell
6,575
-709
-10% -$278K 0.02% 370
2021
Q4 		$3.43M Buy
7,284
+379
+5% +$163K 0.03% 331
2021
Q3 		$2.93M Sell
6,905
-674
-9% -$284K 0.03% 371
2021
Q2 		$2.73M Buy
7,579
+798
+12% +$264K 0.02% 384
2021
Q1 		$1.91M Sell
6,781
-191
-3% -$54.7K 0.01% 409
2020
Q4 		$2.05M Buy
+6,972
New +$1.96M 0.01% 401

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vontobel Holding's WST Position: Q2 2026 in Review

Vontobel Holding reduced its West Pharmaceutical (WST) stake by 0.88% in Q2 2026, selling an estimated $6.12K and leaving 2,254 shares worth $809K. The position accounts for ﹤0.01% of the portfolio, ranked #885.

Vontobel Holding first reported a position in WST in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.43M in Q4 2021. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Vontobel Holding held 2,254 shares of West Pharmaceutical worth $809K as of Q2 2026.
  • Vontobel Holding sold 20 West Pharmaceutical shares in Q2 2026, an estimated $6.12K.
  • West Pharmaceutical made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #885 holding.
  • Vontobel Holding first reported a position in West Pharmaceutical in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's West Pharmaceutical position peaked at $3.43M in Q4 2021.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.